Hints and tips:
Related Special Reports
Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...at high volumes, said Naresh Chouhan, an analyst at Intron Health....
...The US drugmaker last year launched a collaboration with digital health company Ada Health to help patients understand if they met criteria to be prescribed Covid treatments such as Paxlovid....
...Fruergaard Jørgensen said that a tablet product from the acquisition last year of a Canadian biotech, Inversago, could be a scalable weight-loss pill and alternative to the popular GLP-1-based drugs....
...Beacham is sceptical of the companies’ claims about the lower health risks of alternative nicotine products, saying they have failed to “build up trust” with investors due to their history of underplaying...
...“It’s not in a position to provide an alternative to the NHS.”...
...The agreement also prompted the US biotech company to remove a “going concern” notice that was issued a year ago and had put pressure on the stock....
...But it will be companies with large health insurance divisions such as UnitedHealth not traditional retailers, that will have the best shot at capturing more of that $4.5tn pie. pan.yuk@ft.com...
...Shockwave’s technology has treated approximately 400,000 patients globally, the company said....
...On Wednesday J&J said it would pursue alternative ways to resolve the litigation while awaiting approval from claimants....
...Some activists argue that the health of workers, consumers and the public at large poses a financial risk that companies have failed to digest....
...The company has never been frozen in time....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
...The researchers concluded that “the medicines are so expensive they are essentially unavailable unless reimbursed by government or health system authorities”....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...But J&J took it a step further, by filing not the whole $350bn company but a contrived subsidiary. The company had said it would pay up to $60bn of liability....
...Pfizer and BioNTech will dispute Moderna’s ability to withdraw the pledge when it did, given the World Health Organization did not declare the end of the “global health emergency” until March 2023....
...Shah Capital now owns 6.7 per cent of Novavax, having first bought into the company in the last quarter of 2022....
...Instead, Stride said, the government wanted to explore “alternative forms of support”, including vouchers, reimbursement based on receipts, or better access to mental healthcare or local authority care packages...
...“I think the responsibility ought to be entirely with Greg,” Buffett said from the stage at the CHI Health Center in downtown Omaha....
...medical treatments also buoyed pharmaceutical groups such as Moderna and Pfizer in 2020, as well as lesser-known Chinese groups, including WuXi Biologics, Chongqing Zhifei Biological Products and Alibaba Health...
...Despite the frenzy over weight-loss medications, those drugs shouldn’t squeeze out alternatives for tackling this nasty disease. vanessa.houlder@ft.com...
...Because the drug must be grown from enzymes, rather than produced synthetically, it is complex to manufacture and in Europe, generics companies have decided against creating biosimilar alternatives, adds...
...These shifts have led some companies to remove the UK from their supply chains....
International Edition